Biography

Barbara Bodem has served as a director of the Company since March 2022. Prior to her service on the Board, Barbara served as Interim Chief Financial Officer at Dentsply Sirona Inc., from April of 2022 to October 2022. She previously served as Senior Vice President and Chief Financial Officer at Hillrom, a global medical technology company, from 2018 until its acquisition by Baxter International Inc. (NYSE: BAX) in 2021, and as the Senior Vice President of Finance at Mallinckrodt Pharmaceuticals, a pharmaceutical manufacturer, from 2015 to 2018. Barbara has also served in senior finance roles for Hospira, Inc. and Eli Lilly & Company. She currently serves as a director of BioMarin Pharmaceutical, a global biotechnology company (NASDAQ: BMRN), and Option Care Health, the largest national independent provider of infusion therapy (NASDAQ: OPCH). She received both her Bachelor of Science in Finance and MBA from Indiana University. Barbara serves as a member of the Audit Committee of the Board.